Elanco Animal Health Set to Axe Over 400 Employees

Animal Health firm, Elanco, has unveiled plans to redirect resources, which will result in just over 420 jobs being axed.  

The shift is aligned with Elanco’s efforts to drive the adoption of its products and lays the groundwork for the global expansion of products currently under regulatory review.  

The shift is expected to see a net gain of just over $20 million this year, which is set to be reinvested in areas with more growth potential.  

Jeff Simmons, the leading officer at Elanco, stated, “Elanco ended 2023 with momentum, returning to constant currency revenue growth for the full year and delivering 5% growth in the fourth quarter, primarily driven by our farm animal business, innovation revenue, and price growth.”  

Simmons went on to add, “As we look at 2024, we expect our existing portfolio to deliver constant currency revenue growth of 1% to 3%, with both pet health and farm animal expected to contribute to growth.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.